DuPont™ Liveo™ for Healthcare Silicone Solutions Is Introduced

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

September 15, 2020

DuPont is a globally recognized leader in silicone-based technology with more than 70 years of experience advancing healthcare through materials innovation, is introducing DuPont Liveo, a new brand name for its extensive range of silicone healthcare solutions. The news was announced today.

Inspired by the terms “live” and “to be alive,” the new Liveo brand name reflects DuPont Healthcare’s drive to create next-generation, innovative solutions that can help patients live life to the fullest.

“As the new name for the longest legacy in healthcare applied silicones brought by DOW CORNING, Liveo stands for smarter healthcare and positive patient outcomes,” says DuPont Liveo Healthcare Global Marketing Manager Jennifer Gemo Mathis.

More than a name change, the Liveo brand reinforces DuPont’s commitment in healthcare and renewed energy to build on more than 70 years of innovation development capabilities, regulatory and manufacturing know-how, and application expertise.

Historically marketed with a DOW CORNING or SILASTIC trade name, the product offering and packaging material are not changing, and all locations will continue to manufacture the same products, using the same rigorous processes and quality oversight as before. Looking ahead, the Liveo brand will reinforce DuPont’s competitive advantages and leadership positions in three key healthcare markets – Biopharmaceutical Processing, Pharmaceutical Solutions and Medical Devices.

“We are making significant investments in both capital and resources to strengthen our strategic capabilities to support our customers’ leadership in key healthcare industry market segments, and we are particularly proud of the contribution that our teams and products have provided to our customers without disruptions during the COVID-19 pandemic outbreak,” says DuPont Liveo Healthcare Global Business Director Eugenio Toccalino.

The Liveo brand product line includes pharma tubing and overmolded assemblies for single-use systems in biopharma processing, transdermal and topical drug delivery systems, medical adhesives for advanced wound care and ostomy care and wearables, silicone elastomers for a wide range of specialty medical devices, anti-flatulent active pharmaceutical ingredients, silicone antifoams, coating, fluids, emulsions and much more. The Liveo product line continues to be manufactured at the DuPont Healthcare Industries Materials Site (HIMS) in Hemlock, Michigan, USA, which is an ISO 9001:2015 and ISO 14000 registered site and FDA registered utilizing GMPs.

 

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.